Literature DB >> 18973447

Potential for the emergence of Japanese encephalitis virus in California.

R J Nett1, G L Campbell, W K Reisen.   

Abstract

The potential risk for the introduction and establishment of Japanese encephalitis virus (JEV) within California is described based on the literature. JEV is a mosquito-borne arbovirus endemic to Asia that when transmitted to humans can lead to Japanese encephalitis (JE), a disease affecting mostly children with a fatality rate up to 30%. The geographical expansion of JEV in Asia along with the recent introduction and rapid spread of West Nile virus (WNV) across the United States, demonstrates the ability of arboviruses to rapidly extend their distributions. California is at particular risk for the introduction of JEV because it is a large state functioning as a hub for international travel and commerce with Asia, potentially allowing the introduction of mosquitoes infected with JEV. If JEV is introduced into California, the virus might become established due to the significant number of susceptible mosquito vectors and vertebrate hosts. Once introduced, the lack of active surveillance for JEV, the ambiguous clinical presentation of JE, the cross reactivity of serological testing between JEV and other flaviviruses, and the probability that clinicians and laboratories would not consider JE as a possible diagnosis would likely delay recognition. A significant delay in detection of JEV in California would make control and eradication of the virus very difficult and costly. Public health authorities should consider the need for future control efforts if JEV emerges in the United States.

Entities:  

Mesh:

Year:  2009        PMID: 18973447     DOI: 10.1089/vbz.2008.0052

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  15 in total

Review 1.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Meta-Analyses of Japanese Encephalitis Virus Infection, Dissemination, and Transmission Rates in Vectors.

Authors:  Ana R S Oliveira; Lee W Cohnstaedt; Erin Strathe; Luciana Etcheverry; D Scott McVey; José Piaggio; Natalia Cernicchiaro
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

3.  Age-related susceptibility to Japanese encephalitis virus in domestic ducklings and chicks.

Authors:  Natalie B Cleton; Angela Bosco-Lauth; Michael J Page; Richard A Bowen
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

4.  Emergence of zoonotic arboviruses by animal trade and migration.

Authors:  Martin Pfeffer; Gerhard Dobler
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

5.  Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

Authors:  Angela Bosco-Lauth; Gary Mason; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 6.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

7.  North American birds as potential amplifying hosts of Japanese encephalitis virus.

Authors:  Nicole Nemeth; Angela Bosco-Lauth; Paul Oesterle; Dennis Kohler; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

8.  Japanese encephalitis-a pathological and clinical perspective.

Authors:  Debapriya Ghosh; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

Review 9.  Japanese encephalitis - the prospects for new treatments.

Authors:  Lance Turtle; Tom Solomon
Journal:  Nat Rev Neurol       Date:  2018-04-26       Impact factor: 42.937

10.  The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.

Authors:  Kirsten S Vannice; Susan L Hills; Lauren M Schwartz; Alan D Barrett; James Heffelfinger; Joachim Hombach; G William Letson; Tom Solomon; Anthony A Marfin
Journal:  NPJ Vaccines       Date:  2021-06-15       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.